Rhythm Diagnostic Systems
7
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 7 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
An Evaluation of Multisense® to Ensure a Safe Return Home Following High-risk Gastrointestinal Surgery, Compared With Standard Care.
Role: lead
Use of RDS MultiSense® in Post-ICU Patients in the COVID-19 Era
Role: collaborator
RDS MultiSense® SpO2 Validation Study
Role: lead
RDS MultiSense® SpO2 Calibration
Role: lead
Safety and Performance Study of the MultiSense® Ambulatory Telemonitoring System for Non-critical Patient Management
Role: collaborator
Evaluation of RDS MultiSense® in Desaturation Analysis in Healthy Volunteers
Role: collaborator
REmote Data Acquisition After SURgery
Role: collaborator
All 7 trials loaded